Topical application of tranexamic acid after adenoidectomy: a double-blind, prospective, randomized, controlled study

Int J Pediatr Otorhinolaryngol. 2013 Jul;77(7):1139-42. doi: 10.1016/j.ijporl.2013.04.021. Epub 2013 May 10.

Abstract

Objective: Is to evaluate the efficacy of tranexamic acid when applied locally in children after primary isolated adenoidectomy with respect to intra-operative blood loss and post-operative bleeding.

Study design: Prospective, double-blind, randomized, controlled trial.

Setting: Otolaryngology department, Tanta University and Tiba Hospitals, Egypt.

Patients and methods: Over three years, 400 children underwent primary isolated adenoidectomy followed by topical application of tranexamic acid (tranexamic acid group, 200 children) or saline (Placebo group, 200 children) with at least two weeks' follow up. Intra-operative blood loss and post-operative hemorrhage were monitored.

Results: Both groups were almost equivalent in age and gender. The frequency of primary post-adenoidectomy hemorrhage as well as the rate of postnasal packing and blood transfusion required to manage severe bleeding were higher in placebo group. The volume of blood loss during surgery showed significant reduction in tranexamic acid group.

Conclusion: Topical application of tranexamic acid after adenoidectomy led to a significant reduction in blood loss during surgery and decreasing in the rate of post-operative bleeding as well as the need for postnasal packing and blood transfusion.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adenoidectomy*
  • Adolescent
  • Antifibrinolytic Agents / administration & dosage*
  • Antifibrinolytic Agents / therapeutic use
  • Child
  • Child, Preschool
  • Double-Blind Method
  • Female
  • Hemostasis, Surgical / methods
  • Humans
  • Infant
  • Male
  • Postoperative Hemorrhage / drug therapy*
  • Prospective Studies
  • Tranexamic Acid / administration & dosage*
  • Tranexamic Acid / therapeutic use
  • Treatment Outcome

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid